Sign In
Get Clay Free →

Suggestions

    Mike Nohaile

    Chief Scientific Officer at Generate Biomedicines, Inc.

    Mike Nohaile is a biotechnology executive with extensive experience in the pharmaceutical and biotech industries. He is currently the Chief Executive Officer of Prellis Biologics, a position he has held since August 2022.245 Prior to this role, he served as the Chief Scientific Officer at Generate Biomedicines, Inc. from May 2021 to August 2022.5

    Dr. Nohaile's career highlights include:

    1. Senior Vice President of Strategy, Commercialization & Innovation at Amgen (February 2017 - February 2021)5
    2. Global Head of Molecular Diagnostics at Novartis (December 2008 - November 2012)5
    3. Partner at McKinsey & Company (June 2000 - January 2007)5

    He holds a Ph.D. in Molecular and Cell Biology from the University of California, Berkeley, and completed his postdoctoral fellowship at the Massachusetts Institute of Technology (MIT).15 Dr. Nohaile's expertise spans corporate strategy, commercialization, portfolio management, and the application of data, digital health, and artificial intelligence in the biopharmaceutical industry.13

    In addition to his current role, Dr. Nohaile serves on the Board of Directors for Fulgent Genetics, a position he has held since August 2022.15

    Highlights

    Aug 10 · businesswire.com
    Prellis Biologics Appoints New CEO, Raises $35 Million in Series C ...
    Fulgent Genetics Welcomes Dr. Michael Nohaile and Dr. Leonard ...
    Michael Nohaile | Board Member - Fulgent Genetics

    Related Questions

    What are Mike Nohaile's main responsibilities at Prellis Biologics?
    How did Mike Nohaile's role at Amgen prepare him for his current positions?
    What is the EXIS™ platform at Prellis Biologics?
    How did Mike Nohaile contribute to Amgen's digital health and AI efforts?
    What was Mike Nohaile's role at Novartis AG?
    Mike Nohaile
    Add to my network

    Location

    Los Angeles Metropolitan Area
    Location